2003 Pipeline Report
By Rob Camp The pipeline is bursting, with at least the following compounds twinkling in the eyes of scientists around the globe. It is by no means a full list, but those substances in red were presented at the recent…
Critical Issues From TAG’s Forthcoming HCV/HIV Coinfection Report, Version 2.0
Research and Policy Recommendations for HCV/HIV Coinfection By Tracy Swan February 2003 Introduction The unfolding epidemic of hepatitis C virus (HCV) infection is a serious and growing problem. An estimated 170 million people around the world are infected. In the…
A review of ‘Management of Hepatitis C: 2002 Draft Consensus Statement’
by Daniel Raymond TAG reviewed the NIH's draft consensus statement and submitted comments on June 19, 2002. Summary of comments: The recommendation of needle exchange as a prevention strategy should prioritize subgroups of injection drug users at risk of hepatitis…
A Critical Review of the Research and Treatment of Hepatitis C Virus (HCV) and Hepatitis & HIV Coinfection
by Michael Marco and Jeffrey Schouten, M.D. July 14, 2000 Introduction By Michael Marco "Clearly the problem of HCV will require a responsible partnership of public and private organizations. . . . If we are to make progress against this…